IMV Stock Quote IMV - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.12

Bid

0.60

Ask

0.70

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

1.12

Open

Last Trade

Last Trade Time

Average Volume (3m)

Financial Volume

VWAP

FeaturedELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES

Horizon Technology Finance Announces First Quarter 2023 Financial Results

Horizon Technology Finance Announces First Quarter 2023 Financial Results PR Newswire FARMINGTON, Conn., May 2, 2023 - First Quarter 2023 Net Investment Income per Share of $0.46; NAV per Share...

Suspension de la négociation par l'OCRCVM - IMV

Suspension de la négociation par l'OCRCVM - IMV Canada NewsWire TORONTO, le 1er mai 2023 TORONTO, le 1er mai 2023 /CNW/ - L'OCRCVM a suspendu la négociation des titres suivants...

IIROC Trading Halt - IMV

IIROC Trading Halt - IMV Canada NewsWire TORONTO, May 1, 2023 TORONTO, May 1, 2023 /CNW/ - The following issues have been halted by IIROC: Company: IMV Inc. TSX Symbol: IMV All Issues:...

TMX Group, IMV, C-Suite at The Open

TMX Group, IMV, C-Suite at The Open Canada NewsWire TORONTO, Dec. 9, 2020 TORONTO, Dec. 9, 2020 /CNW/ - Fred Ors, CEO, IMV Inc. (TSX: IMV), shares his company's story in an interview with TMX...

IMV fournit une mise à jour sur son programme de vaccin COVID-19

Sélectionnée par le gouvernement canadien pour recevoir un financement supplémentaire, portant le soutien à un total de 10 millions de dollars à ce jour pour le développement clinique et la...

IMV to Participate at Four Upcoming Investor Conferences

IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious...

IMV Inc. Announces Second Quarter 2020 Financial Results

Rapidly progressing DPX-COVID-19, including Health Canada agreement on Phase 1 clinical study design protocol, with preliminary results expected in fall 2020 Confirmed $4.75M of non-dilutive...

IMV reçoit des subventions de la part d’agences gouvernementales pour la phase 1 du développement clinique du vaccin cont...

Ces subventions d’un total de 4,75 millions soutiendront la fabrication du vaccin et l’étude clinique de phase 1 IMV Inc. (Nasdaq: IMV; TSX: IMV), une société biopharmaceutique (la « Société »...

IMV Receives Funding From Canadian Governmental Agencies for COVID-19 Vaccine Phase 1 Clinical Study

Contribution totalling Cdn$4.75 Million will support Phase 1 clinical development and manufacturing of DPX-COVID-19 IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	-21.28	-95	22.4	30	0.62	63985	13.36454087	CS
260	-36.18	-96.9973190349	37.3	92.5	0.62	109105	38.12228914	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NCPNickel Creek Platinum Corp	$ 0.015 (50.00%)	26.06k
FLNTFlint Corporation	$ 0.035 (40.00%)	104.5k
BNGBengal Energy Ltd	$ 0.025 (25.00%)	1,000
IVQInvesque Inc	$ 0.25 (19.05%)	18.97k
AEGAegis Brands Inc	$ 0.39 (18.18%)	1.5k
NCFNorthcliff Resources Ltd	$ 0.02 (-20.00%)	6k
GFPGreenFirst Forest Products Inc	$ 0.30 (-16.67%)	182.86k
XLYAuxly Cannabis Group Inc	$ 0.03 (-14.29%)	257.81k
NUMINuminus Wellness Inc	$ 0.04 (-11.11%)	194.33k
MPVDMountain Province Diamonds Inc	$ 0.125 (-10.71%)	82.5k
TDToronto Dominion Bank	$ 81.76 (2.17%)	8.73M
ENBEnbridge Inc	$ 51.55 (1.40%)	8.3M
BTEBaytex Energy Corp	$ 4.87 (0.83%)	6.67M
FILFilo Corp	$ 32.01 (8.80%)	6.24M
BNSBank of Nova Scotia	$ 64.21 (0.91%)	5.49M